www.iterumtx.com
Open in
urlscan Pro
3.124.179.217
Public Scan
Submitted URL: http://www.iterumtx.com/
Effective URL: https://www.iterumtx.com/
Submission: On September 18 via api from US — Scanned from DE
Effective URL: https://www.iterumtx.com/
Submission: On September 18 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET /search
<form action="/search" method="get">
<label for="search-default" class="sr-only">Search Term</label>
<input type="text" name="q" id="search-default" placeholder="Search">
<button type="submit"><span class="glyphicon glyphicon-search"></span></button>
</form>
Text Content
This website uses cookies to help us provide you with a more responsive and personalized service. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies and how to delete or block the use of cookies, please see our Cookies Policy. Accept Search Term * Home * About Us * Our Company * Senior Management * Board of Directors * Venture Investors * Our Science * Our Challenge * Our Promise * Pipeline * Publications * Investors * Overview * Press Releases * Events & Presentations * Financials & Filings * Stock Information * Analyst Coverage * Corporate Governance * FAQ * News * Press Releases * External News Links * Careers * Career Opportunities * Contact Us * Global Locations * Partnering Opportunities * Search Back to top OUR CHALLENGE ANTIBIOTIC RESISTANT INFECTIONS Every year, at least two million Americans are infected with bacteria that resist antibiotics. At least 23,000 people die as a direct result. Multi-drug resistant pathogens are a global crisis. Physicians and patients urgently need new options. Learn More OUR PROMISE NEW EFFECTIVE ORAL TREATMENTS Responding to specific medical need, Iterum is developing sulopenem - the first oral and IV penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative infections in both the hospital and community settings Learn More Tackling serious challenges, delivering unique solutions ABOUT US Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens. Our Company CAREERS Our culture is defined by collaboration and a shared motivation to leverage the power of ingenuity to develop new solutions that address the ever-increasing global threat of resistant bacterial infections. Career Opportunities INVESTORS September 16, 2022 3:59 PM EDT MARKET/SYMBOL Nasdaq: ITRM LAST $1.92 CHANGE -0.08 (-4.00%) VOLUME 123.59k DAY RANGE 1.84 - 2.0101 YEAR RANGE 1.84 - 11.25 View Investors Iterum Therapeutics plc Fitzwilliam Court, 1st Floor. Leeson Close. Dublin 2, D02 YW24. Ireland. All Rights Reserved. Iterum Therapeutics plc 2022. Terms of Use Privacy Statement Cookies Statement Home About Us Our Science Investors News Careers Contact Us Search Sitemap Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.